loading
Notification of Major Interest in Shares
09 October 2015
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
Futura Medical plc | ||
| 2 Reason for the notification (please tick the appropriate box or boxes): | |||
| An acquisition or disposal of voting rights | X | ||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||
| An event changing the breakdown of voting rights | |||
| Other (please specify): | |||
| 3. Full name of person(s) subject to the notification obligation: |
Henderson Global Investors | ||
| 4. Full name of shareholder(s) (if different from 3.): |
|||
| 5. Date of the transaction and date on which the threshold is crossed orreached: | 7 October 2015 | ||
| 6. Date on which issuer notified: | 8 October 2015 | ||
| 7. Threshold(s) that is/are crossed or reached: | Above 19% | ||
| 8. Notified details: | |||||||||||||||
| A: Voting rights attached to shares | |||||||||||||||
| Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | |||||||||||||
| Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights | |||||||||||
| Direct | Direct | Indirect | Direct | Indirect | |||||||||||
| Ordinary GB0033278473 |
17,834,126 | 17,834,126 | 18,848,039 | 19.03% | |||||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Expiration date | Exercise/ Conversion Period | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | ||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Exercise price | Expiration date | Exercise/ Conversion period |
Number of voting rights instrument refers to | % of voting rights | |||||||||||
| Nominal | Delta | |||||||||||||||
| Total (A+B+C) | |
| Number of voting rights | Percentage of voting rights |
| 18,848,039 | 19.03% |
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | ||
| 11. Number of voting rights proxy holder will cease to hold: | ||
| 12. Date on which proxy holder will cease to hold voting rights: | ||
| 13. Additional information: | This disclosure has been calculated based on total voting rights amount of 99,022,600. | |
| 14. Contact name: | Scott Dickenson | |
| 15. Contact telephone number: | 020 7818 4184 | |
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
Angela Hildreth, Finance Director and COO
+44 (0) 1483 685 670
james.barder@futuramedical.com
angela.hildreth@futuramedical.com
www.futuramedical.com
Nominated Adviser:
N+1 Singer
Aubrey Powell / Liz Yong
Tel: +44 (0) 20 7496 3000
For media enquiries please contact:
Buchanan
Mark Court / Sophie Wills /
Stephanie Watson / Tilly Abraham
Tel: +44 (0) 20 7466 5000
